Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

Clinical trial NCT02906930 · COMPLETED

Trial details

NCT number

NCT02906930

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2016-09-20

Primary completion

2017-10-30

Enrollment

703

View on ClinicalTrials.gov